Načítá se...
Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB(1)) receptors are potent analgesics devoid of tolerance
Given that mu opioid (MOP) and canabinoid (CB(1)) receptors are co-localized in various regions of the CNS and have been reported to associate as heteromer (MOP-CB(1)) in cultured cells has raised the possibility of functional, endogenous MOP-CB(1) in nociception and other pharmacologic effects. As...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3849126/ https://ncbi.nlm.nih.gov/pubmed/23734559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm4005219 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|